+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Screening for VPS35 mutations in Parkinson's disease



Screening for VPS35 mutations in Parkinson's disease



Neurobiology of Aging 33(4): 838.E1-5



Recently 2 groups have independently identified a mutation in the gene 'vacuolar protein sorting 35 homolog' (VPS35 c.1858G>A; p.Asp620Asn) as a possible cause of autosomal dominant Parkinson's disease (PD). In order to assess the frequency of the reported mutation and to search for other possible disease-causing variants in this gene, we sequenced all 17 exons of VPS35 in 96 familial PD cases, and exon 15 (in which the reported mutation is found) in an additional 64 familial PD cases, 175 young-onset PD cases, and 262 sporadic, neuropathologically confirmed PD cases. We identified 1 individual with the p.Asp620Asn mutation and an autosomal dominant family history of PD. Subsequent follow-up of the family confirmed an affected sibling and cousin who also carried the same mutation. No other potentially disease-causing mutations were identified. We conclude that the VPS35 c.1858G>A mutation is an uncommon cause of familial Parkinson's disease in our population.

(PDF emailed within 0-6 h: $19.90)

Accession: 055670864

Download citation: RISBibTeXText

PMID: 22154191

DOI: 10.1016/j.neurobiolaging.2011.10.032


Related references

VPS35 mutations in Parkinson disease. American Journal of Human Genetics 89(1): 162-167, 2011

Contributions of VPS35 mutations to Parkinson's Disease. Neuroscience 2019, 2019

VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians. Neurobiology of Aging 34(10): 2442.E1-3, 2014

Identification of VPS35 mutations replicated in French families with Parkinson disease. Neurology 78(18): 1449-1450, 2012

Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Human Molecular Genetics 23(17): 4621-4638, 2015

An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease. Neuroscience Letters 610: 135-138, 2016

VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China. Neurobiology of Aging 34(6): 1709.E7-8, 2013

EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa. Neurobiology of Aging 35(2): 445.E1-3, 2014

Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil. Neuroscience Letters 635(): 67-70, 2016

The VPS35 gene and Parkinson's disease. Movement Disorders 28(5): 569-575, 2014

VPS35: A new player in Parkinson's disease. Movement Disorders 26(10): 1803-1803, 2011

VPS35, the Retromer Complex and Parkinson's Disease. Journal of Parkinson's Disease 7(2): 219-233, 2017

Deciphering the role of VPS35 in Parkinson's disease. Journal of Neuroscience Research: -, 2018

Frequency of the D620N mutation in VPS35 in Parkinson disease. Archives of Neurology 69(10): 1360-1364, 2013

Linking the VPS35 and EIF4G1 pathways in Parkinson's disease. Neuron 85(1): 1-3, 2015